209 related articles for article (PubMed ID: 33733032)
1. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.
Ageno W; Farjat A; Haas S; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
Res Pract Thromb Haemost; 2021 Feb; 5(2):326-341. PubMed ID: 33733032
[TBL] [Abstract][Full Text] [Related]
2. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
3. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
4. The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
Goto S; Turpie AGG; Farjat AE; Weitz JI; Haas S; Ageno W; Goldhaber SZ; Angchaisuksiri P; Kayani G; MacCallum P; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
Thromb Res; 2021 Jul; 203():155-162. PubMed ID: 34023735
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
6. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
Chen AC; Rao AS; Oropallo A; Goldhaber SZ; Fluharty ME; Maheshwari U; Carrier M; Turpie AGG; Pieper K; Kayani G; Kakkar AK;
Thromb Res; 2023 Dec; 232():123-132. PubMed ID: 37976732
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE.
Giustozzi M; Valerio L; Agnelli G; Becattini C; Fronk EM; Klok FA; Konstantinides SV; Vedovati MC; Cohen AT; Barco S
Eur J Intern Med; 2021 Jun; 88():43-51. PubMed ID: 33810940
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
[TBL] [Abstract][Full Text] [Related]
9. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
Gabara C; Aibar J; Nishimoto Y; Yamashita Y; Prandoni P; Barnes GD; Bikdeli B; Jiménez D; Demelo-Rodríguez P; Peris ML; Nguyen ST; Monreal M;
J Thromb Haemost; 2024 May; ():. PubMed ID: 38762019
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
Kearon C; Parpia S; Spencer FA; Schulman S; Stevens SM; Shah V; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Connors JM; Ginsberg JS; Spadafora L; Julian JA
J Thromb Haemost; 2019 Jul; 17(7):1144-1152. PubMed ID: 31033194
[TBL] [Abstract][Full Text] [Related]
12. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
Turpie AGG; Farjat AE; Haas S; Ageno W; Weitz JI; Goldhaber SZ; Goto S; Angchaisuksiri P; Kayani G; Lopes RD; Chiang CE; Gibbs H; Tse E; Verhamme P; Ten Cate H; Muntaner J; Schellong S; Bounameaux H; Prandoni P; Maheshwari U; Kakkar AK;
Thromb Res; 2023 Feb; 222():31-39. PubMed ID: 36565677
[TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of venous thromboembolism: Are all transient provoking events the same?
Chua CC; Lim HY; Tacey M; Nandurkar H; Ho P
Eur J Haematol; 2017 Jul; 99(1):18-26. PubMed ID: 28321922
[TBL] [Abstract][Full Text] [Related]
14. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
[TBL] [Abstract][Full Text] [Related]
15. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
[TBL] [Abstract][Full Text] [Related]
17. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis.
de Winter MA; Uijl A; Büller HR; Carrier M; Cohen AT; Hansen JB; Kaasjager KHAH; Kakkar AK; Middeldorp S; Raskob GE; Sørensen HT; Wells PS; Nijkeuter M; Dorresteijn JAN
J Thromb Haemost; 2023 Mar; 21(3):573-585. PubMed ID: 36696208
[TBL] [Abstract][Full Text] [Related]
18. Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism.
White RH; Murin S; Wun T; Danielsen B
J Thromb Haemost; 2010 May; 8(5):987-97. PubMed ID: 20149075
[TBL] [Abstract][Full Text] [Related]
19. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
[TBL] [Abstract][Full Text] [Related]
20. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]